LifeMD (LFMD) Net Income towards Common Stockholders (2012 - 2025)

LifeMD's Net Income towards Common Stockholders history runs 14 years deep, the most recent figure standing at $19.2 million for Q4 2025.

• Quarterly Net Income towards Common Stockholders rose 435.72% year-over-year to $19.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.1 million (up 153.51% YoY) and the FY2025 annual result came in at $11.2 million, up 145.88% from the prior year.
• Net Income towards Common Stockholders was $19.2 million for Q4 2025 at LifeMD, up from -$4.6 million in the prior quarter.
• Across five years, Net Income towards Common Stockholders topped out at $19.2 million in Q4 2025 and bottomed at -$19.0 million in Q4 2021.
• A 5-year average of -$7.3 million and a median of -$7.5 million in 2023 frame the typical range for Net Income towards Common Stockholders.
• Annual changes were most pronounced in 2021 — Net Income towards Common Stockholders plunged 398.08% — and 2025, when it jumped 435.72%.
• LifeMD's Net Income towards Common Stockholders stood at -$19.0 million in 2021, then jumped by 33.03% to -$12.7 million in 2022, then soared by 64.53% to -$4.5 million in 2023, then declined by 26.76% to -$5.7 million in 2024, then soared by 435.72% to $19.2 million in 2025.
• Business Quant data shows LFMD's Net Income towards Common Stockholders at $19.2 million in Q4 2025, -$4.6 million in Q3 2025, and $455210.0 in Q2 2025.